Skip to content
Back to Investors
LV

Labcorp Venture Fund

Corporate

Portfolio

1

companies

Investment by month

By category

  • FemTech£6.8M

By location

  • London£6.8M

Portfolio companies

E

Emm

Emm develops biowearable technology designed to provide actionable insights into menstrual health.


Team

Megann Vaughn Watters

Megann Vaughn Watters

VP of New Ventures and Strategic Alliances

Megann manages the Labcorp Venture Fund and leads new ventures and strategic alliances. Her background includes corporate development and patent examination.

LinkedIn

Recent investments

Seed
£6.8M

The financing round was led by Lunar Ventures to support product commercialisation and clinical development.

"Menstruation is known as the fifth vital sign, but has historically been overlooked by the wearable sector, leaving millions without the data they need to understand and advocate for their own bodies. We envision a future where menstrual health is measured and understood as comprehensively as cardiovascular or metabolic health, giving people access to objective, actionable insights to better manage their health and wellbeing."
— Jenny Button, Founder and CEO